Krensavage Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-73,745
Closed -$15.2M 22
2025
Q4
$15.2M Hold
73,745
5.35% 9
2025
Q3
$11.6M Sell
73,745
-60,000
-45% -$9.27M 4.93% 10
2025
Q2
$22.5M Sell
133,745
-55,000
-29% -$8.16M 11.89% 2
2025
Q1
$26M Sell
188,745
-20,100
-10% -$2.56M 14.38% 3
2024
Q4
$24.7M Sell
208,845
-1,418
-0.7% -$166K 14.61% 3
2024
Q3
$23.2M Sell
210,263
-7,393
-3% -$773K 13.02% 3
2024
Q2
$21.4M Sell
217,656
-18,000
-8% -$1.83M 9.83% 5
2024
Q1
$26.4M Sell
235,656
-45,820
-16% -$4.94M 11.69% 5
2023
Q4
$28.4M Sell
281,476
-9,843
-3% -$977K 10.07% 5
2023
Q3
$25.3M Sell
291,319
-62,395
-18% -$5.64M 9.31% 6
2023
Q2
$33.5M Buy
353,714
+436
+0.1% +$36.8K 10.6% 6
2023
Q1
$26.7M Buy
353,278
+20,529
+6% +$1.55M 8.1% 7
2022
Q4
$25.6M Sell
332,749
-3,993
-1% -$303K 7.9% 8
2022
Q3
$22.5M Buy
336,742
+157,903
+88% +$10M 7.15% 8
2022
Q2
$9.35M Buy
178,839
+165,639
+1,255% +$9.41M 3.09% 10
2022
Q1
$748K Buy
+13,200
New +$707K 0.26% 11

Other funds holding CAH

Krensavage Asset Management's CAH Position: Q1 2026 in Review

Krensavage Asset Management sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 73,745 shares — an estimated $15.2M sold.

Krensavage Asset Management first reported a position in CAH in Q1 2022 and held it in 16 quarters. The position peaked at $33.5M in Q2 2023. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Krensavage Asset Management reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Krensavage Asset Management sold 73,745 Cardinal Health shares in Q1 2026, an estimated $15.2M.
  • Krensavage Asset Management first reported a position in Cardinal Health in Q1 2022 and held it in 16 quarters.
  • Krensavage Asset Management's Cardinal Health position peaked at $33.5M in Q2 2023.
  • 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Krensavage Asset Management's 13F filing for Q1 2026, filed 15 May 2026.